Solarc Systems Inc.

Get 5% off any Solrx device or $100.00 off any Package deal. Follow this link to save today https://solarcsystems.ca/

A recent study published in the Journal of the American Academy of Dermatology found that ultraviolet B phototherapy does not increase the risk of skin cancer among patients with atopic dermatitis. The results showed that neither UV-B phototherapy nor the number of UV-B phototherapy sessions was associated with an increased risk of skin cancers among patients with AD. If you have atopic dermatitis, this is great news! Phototherapy is a safe and effective treatment option for many people with this condition.

Ultraviolet B phototherapy does not increase the risk of skin cancer among patients with atopic dermatitis: A population-based retrospective cohort study UV-B phototherapy is a common treatment modality for patients with atopic dermatitis (AD), but its long-term safety in terms of cutaneous carcinogenic risk has not been studied.

An interesting new study has shown "people with vitiligo have a markedly lower risk of both melanoma and non-melanoma skin cancer compared to the general population."

It also stated that "Given concerns that some treatments for vitiligo, such as prolonged phototherapy, may increase skin cancer risk, the demonstrated reduction in skin cancer incidence should be reassuring to both people with vitiligo and clinicians managing the condition.”

Another win for phototherapy!

Read more here: https://www.dermatologyadvisor.com/home/topics/skin-cancer/vitiligo-reduced-incidences-skin-cancer/

"Narrow-band ultraviolet B home phototherapy was found to be an effective form of maintenance therapy for photoresponsive diseases. It is safe and presents few side effects when patients receive appropriate guidelines, teaching, and follow-ups."

Check out the following study to learn how home phototherapy is an effective alternative to clinical phototherapy, without having to visit a clinic multiple times per week!

Are narrow-band ultraviolet B home units a viable option for continuous or maintenance therapy of photoresponsive diseases? - PubMed Narrow-band ultraviolet B home phototherapy was found to be an effective form of maintenance therapy for photoresponsive diseases. It is safe and presents few side effects when patients receive appropriate guidelines, teaching, and follow-ups.